The Phelan-McDermid Syndrome Foundation (PMSF) is pleased to announce the appointment of Christopher Winrow, PhD, to its Board of Directors, effective June 1, 2026. A longtime advocate within the Phelan-McDermid syndrome community and an accomplished neuroscience and biotech leader, Dr. Winrow brings decades of experience in drug discovery, strategic leadership, and patient advocacy to the Foundation.